يعرض 11 - 20 نتائج من 359 نتيجة بحث عن '"Anhidrotic"', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 11
    دورية أكاديمية
  2. 12
    دورية أكاديمية
  3. 13
  4. 14
    دورية أكاديمية
  5. 15
    دورية أكاديمية

    المصدر: Disease models & mechanisms, vol. 12, no. 4

    وصف الملف: application/pdf

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31028034; info:eu-repo/semantics/altIdentifier/eissn/1754-8411; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4103E7371D490; https://serval.unil.ch/notice/serval:BIB_4103E7371D49Test; urn:issn:1754-8403; https://serval.unil.ch/resource/serval:BIB_4103E7371D49.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_4103E7371D490Test

  6. 16
    دورية أكاديمية

    المساهمون: Not specified, Не указан

    المصدر: Current Pediatrics; Том 19, № 6 (2020); 483-489 ; Вопросы современной педиатрии; Том 19, № 6 (2020); 483-489 ; 1682-5535 ; 1682-5527

    وصف الملف: application/pdf

    العلاقة: https://vsp.spr-journal.ru/jour/article/view/2510/987Test; Fortin M., Bravo G., Hudon C., et al. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3(3): 223–228. doi:10.1370/afm.272.; Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56–68. doi:10.1038/nrg2918.; Пантелеева Г.А., Суздальцева И.В., Гончаренко Т.С. Клинические примеры редкого сочетания дерматозов // Клиническая дерматология и венерология. — 2011. — № 4. — С. 21–25.; Рыжкова О.П., Кардымон О.Л., Прохорчук Е.Б. и др. Руководство по интерпретации данных последовательности ДНК человека, полученных методами массового параллельного секвенирования (MPS) (редакция 2018, версия 2) // Медицинская генетика. — 2019. — Т. 18. — № 2. — С. 3–23. doi:10.25557/2073-7998.2019.02.3-23.; Лазебник Л.Б. Полиморбидность и старение // Новости медицины и фармации. — 2007. — № 1(205).; Smith SM, Wallace E, O’Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2016; 14(3):CD006560. doi:10.1002/14651858.CD006560.pub3.; Glynn LG, Jose MV, Pamela H, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28(5):516–523. doi:10.1093/fampra/cmr013.; Sambamoorthi U, Tan X, Deb A. Multiple chronic conditions and healthcare costs amongadults. Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):823–832. doi:10.1586/14737167.2015.1091730.; Ren Z, Hsu DY, Brieva J, et al. Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A. Br J Dermatol. 2017;176(1):87–99. doi:10.1111/bjd.14821.; Santolini M, Barabasi AL. Predicting perturbation patterns from the topology of biological networks. Proc Natl Acad Sci USA. 2018;115(27):E6375–E6383. doi:10.1073/pnas.1720589115.; Kitsak M, Sharma A, Menche J, et al. Tissue Specificity of Human Disease Module. Sci Rep. 2016;6:35241. doi:10.1038/srep35241.; Lage K, Hansen NT, Karlberg EO, et al. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci USA. 2008;105(52): 20870–20875. doi:10.1073/pnas.0810772105.; Barshir R, Shwartz O, Smoly IY, Yeger-Lotem E. Comparative analysis of human tissue interactomes reveals factors leading to tissue-specific manifestation of hereditary diseases. PLoS Comput Biol. 2014;10(6):e1003632. doi:10.1371/journal.pcbi.1003632.; Pandey AK, Lu L, Wang X, et al. Functionally enigmatic genes: a case study of the brain ignorome. PLoS One. 2014;9(2):e88889. doi:10.1371/journal.pone.0088889.; Greene CS, Krishnan A, Wong AK, et al. Understanding multicellular function and disease with human tissue-specific networks. Nat Genet. 2015;47(6):569–576. doi:10.1038/ng.3259.; Eytan O, Sarig O, Sprecher E, van Steensel MAM. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14. Br J Dermatol. 2014;171(2):420–422. doi:10.1111/bjd.12952.; S. Philipp A, Menter AF, Nikkels K, et al. Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients ( 6 to < 12 years of age): efficacy, safety, pharmacokinetic, and biomarker results from the open-label CADMUS Jr study. Br J Dermatol. 2020 Mar 16. Online ahead of print. doi:10.1111/bjd.19018.; https://vsp.spr-journal.ru/jour/article/view/2510Test

  7. 17
  8. 18
    دورية أكاديمية

    المصدر: The New England Journal of Medicine, vol. 378, no. 17, pp. 1604-1610

    وصف الملف: application/pdf

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29694819; info:eu-repo/semantics/altIdentifier/eissn/1533-4406; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_7D5E9C7A775B4; https://serval.unil.ch/notice/serval:BIB_7D5E9C7A775BTest; urn:issn:0028-4793; https://serval.unil.ch/resource/serval:BIB_7D5E9C7A775B.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_7D5E9C7A775B4Test

  9. 19
    دورية أكاديمية
  10. 20
    دورية أكاديمية

    المساهمون: University of Helsinki, Institute for Molecular Medicine Finland, Institute of Biotechnology, Medicum, Department of Clinical Chemistry and Hematology, Research Programs Unit, Päivi Marjaana Saavalainen / Principal Investigator, Research Programme of Molecular Medicine, Jussi Taipale / Principal Investigator, Genome-Scale Biology (GSB) Research Program, Clinicum, Nefrologian yksikkö, Department of Medicine, Diabetes and Obesity Research Program, Reumatologian yksikkö, Infektiosairauksien yksikkö, Department of Oncology, Janna Saarela / Principal Investigator, Juha Kere / Principal Investigator, Research Programme for Molecular Neurology, Molecular Systems Biology, Children's Hospital, HUS Children and Adolescents, HUS Comprehensive Cancer Center, HUS Inflammation Center, HUSLAB, HUS Internal Medicine and Rehabilitation, HUS Abdominal Center

    وصف الملف: application/pdf

    العلاقة: Supported by the Academy of Finland (nos. 288475 and 294173), the Sigrid Juselius Foundation, the Emil Aaltonen Foundation, the Finnish Medical Foundation, the Jane and Aatos Erkko Foundation, the Alma and K.A. Snellman Foundation, Biocentrum Helsinki, the Instrumentarium Science Foundation, the Finnish Cancer Institute, the Foundation for Pediatric Research, the Biomedicum Helsinki Foundation, the Integrative Life Science Doctoral Program (ILS) and Doctoral Programme in Biomedicine of the University of Helsinki, Karolinska Institutet Distinguished Professor Award, the Strategic Research Program for Diabetes Funding at Karolinska Institutet, and the Swedish Research Council.; Kaustio , M , Haapaniemi , E , Göös , H , Hautala , T , Park , G , Syrjänen , J , Einarsdottir , E , Sahu , B , Kilpinen , S , Rounioja , S , Fogarty , C L , Glumoff , V , Kulmala , P , Katayama , S , Tamene , F , Trotta , L , Morgunova , E , Krjutskov , K , Nurmi , K , Eklund , K , Lagerstedt , A , Helminen , M , Martelius , T , Mustjoki , S , Taipale , J , Saarela , J , Kere , J , Varjosalo , M & Seppanen , M 2017 , ' Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes ' , Journal of Allergy and Clinical Immunology , vol. 140 , no. 3 , pp. 782-796 . https://doi.org/10.1016/j.jaci.2016.10.054Test; ORCID: /0000-0001-6576-5440/work/39200615; ORCID: /0000-0002-0853-6219/work/39889929; ORCID: /0000-0002-1340-9732/work/37568859; ORCID: /0000-0002-6175-4872/work/40341244; ORCID: /0000-0001-9733-3650/work/39204273; ORCID: /0000-0002-0816-8241/work/39901439; 85013392319; e461792b-bfb1-4d0f-845e-5f671ba1330c; http://hdl.handle.net/10138/297945Test; 000409241500017